Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study (CTS).

Trial Profile

Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study (CTS).

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Belatacept (Primary) ; Calcineurin inhibitors
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Acronyms CTS
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 18 Sep 2017 Status changed from active, no longer recruiting to completed.
    • 07 Aug 2017 Planned End Date changed from 30 Apr 2018 to 30 Aug 2017.
    • 07 Aug 2017 Planned primary completion date changed from 30 Apr 2018 to 30 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top